These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20647826)

  • 1. Evaluation of the safety of nevirapine therapy during pregnancy.
    Bersoff-Matcha SJ; Rourke D; Blank J
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):560-2. PubMed ID: 20647826
    [No Abstract]   [Full Text] [Related]  

  • 2. Reports on nevirapine threaten public health.
    Lane HC; Folkers GK; Fauci AS
    Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.
    Cohen J
    Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490
    [No Abstract]   [Full Text] [Related]  

  • 4. Nevirapine toxicity--implications for management of South African patients.
    Wood R
    S Afr Med J; 2005 Apr; 95(4):253-7. PubMed ID: 15889848
    [No Abstract]   [Full Text] [Related]  

  • 5. AIDS research. IOM panel clears HIV prevention study.
    Couzin J
    Science; 2005 Apr; 308(5720):334. PubMed ID: 15831722
    [No Abstract]   [Full Text] [Related]  

  • 6. Nevirapine may promote resistance.
    AIDS Patient Care STDS; 2004 Apr; 18(4):249-50. PubMed ID: 15154406
    [No Abstract]   [Full Text] [Related]  

  • 7. Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1.
    Stringer JS; Sinkala M; Goldenberg R; Vermund S; Acosta E
    Lancet; 2003 Aug; 362(9384):667. PubMed ID: 12944077
    [No Abstract]   [Full Text] [Related]  

  • 8. HIVNET 012 and Petra.
    Jackson B; Mmiro F;
    Lancet; 2004 Jan; 363(9404):245; author reply 245-6. PubMed ID: 14738808
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIVNET 012 and Petra.
    Cooper E
    Lancet; 2004 Jan; 363(9404):244; author reply 245-6. PubMed ID: 14738806
    [No Abstract]   [Full Text] [Related]  

  • 11. Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
    Kuhn L; Sinkala M; Kankasa MP; Kasonde P; Thea DM; Aldrovandi GM
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):260-2. PubMed ID: 16760802
    [No Abstract]   [Full Text] [Related]  

  • 12. HIVNET 012 and Petra.
    Wilfert CM
    Lancet; 2004 Jan; 363(9404):244-5; author reply 245-6. PubMed ID: 14738805
    [No Abstract]   [Full Text] [Related]  

  • 13. The controversies of nevirapine for preventing mother-to-child HIV transmission.
    Smith DM
    AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423
    [No Abstract]   [Full Text] [Related]  

  • 14. HIVNET 012 and Petra.
    Hudson CP
    Lancet; 2004 Jan; 363(9404):243; author reply 244. PubMed ID: 14738804
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].
    Kazennova EV
    Vopr Virusol; 2009; 54(1):45-8. PubMed ID: 19253732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May; 94(5):338. PubMed ID: 15211947
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV: mother to child transmission.
    Volmink J
    Clin Evid; 2003 Jun; (9):785-94. PubMed ID: 12967392
    [No Abstract]   [Full Text] [Related]  

  • 18. Scaling the frontier--should traditional birth attendants also be used to provide nevirapine for PMTCT in Uganda?
    Kironde S; Lukwago J; Ssenyonga R
    Afr Health Sci; 2003 Aug; 3(2):102-3. PubMed ID: 12913802
    [No Abstract]   [Full Text] [Related]  

  • 19. Feeding risk cut for HIV-infected women.
    Das P
    Lancet; 2003 Jul; 362(9380):300. PubMed ID: 12892984
    [No Abstract]   [Full Text] [Related]  

  • 20. [Encouraging study results. HIV from birth on--virostatic drugs can decrease the risk].
    MMW Fortschr Med; 1999 Aug; 141(34):61. PubMed ID: 10726137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.